Luca Boldrini

Università Cattolica del Sacro Cuore, Roma, Italia

Luca Boldrini obtained his Medical Degree and completed his residency program in Radiotherapy at the Università Cattolica del Sacro Cuore of Rome, Italy. 

He currently works as Radiation Oncologist at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS - Università Cattolica del Sacro Cuore of Rome, where he is involved in the MRI guided radiotherapy research program.

His primary research interests include MRI guided radiotherapy, radiomics, imaging applications in the frame of personalised medicine and innovative technologies implementation in cancer care.

He is author of numerous scientific publication, books, and e-publications. 
He is clinical coordinator of the radiomics research program of the Knowledge Based Oncology Lab (KBO Lab) of Rome, Italy.

He is currently a Ph.D. student in Oncological Sciences focusing on “Radiation Oncology, imaging and technological innovation” at the Università Cattolica del Sacro Cuore of Rome, Italy and member of several national and
international scientific associations.

dont miss

Radiomics applications rectal cancer: the MRIdian perspective

The seminar will describe the potentialities of low T MRI guided hybrid Radiotherapy from a radiomics perspective. The talk will be focused on radiomics based prediction models for complete clinical response in rectal cancer patients undergoing neoadjuvant chemoradiotherapy.

EVEN MORE SEMINARS

  • Mr Hamish Clouston: Speaking at the Oncology Convention

    Mr Hamish Clouston
    The Christie NHS Foundation Trust

    Surgical Management of Advanced Colonic and Rectal Malignancies.

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Prantik Das: Speaking at the Oncology Convention

    Prantik Das
    University Hospital of Derby and Burton NHS Foundation Trust

    The Changing Landscape of Prostate Radiotherapy

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer